| 國家衛生研究院 |
2018-10 |
EGFR, SMAD7, and TGFBR2 polymorphisms are associated with colorectal cancer in patients with lynch syndrome
|
Kamiza, AB;Wang, WC;You, JF;Tang, R;Wang, YT;Chien, HT;Lai, CH;Chiu, LP;Lo, TP;Hung, KY;Hsiung, CA;Yeh, CC |
| 臺大學術典藏 |
2020-12-02T02:33:27Z |
EGFR-activating mutations, DNA copy number abundance of ErbB family, and prognosis in lung adenocarcinoma
|
Chen H.-Y.; Liu C.-H.; Chang Y.-H.; Yu S.-L.; Ho B.C.; Hsu C.-P.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Hsia J.-Y.; Chuang C.-Y.; Chang C.-S.; Li Y.-C.; Li K.-C.; Chang G.-C.; Pan-Chyr Yang; Chen H.-Y.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2021-03-03T08:35:09Z |
EGFR-driven up-regulation of decoy receptor 3 in keratinocytes contributes to the pathogenesis of psoriasis
|
Wu N.-L.;Huang D.-Y.;Hsieh S.-L.;Hsiao C.-H.;Lee T.-A.;Wan-Wan Lin; Wu N.-L.; Huang D.-Y.; Hsieh S.-L.; Hsiao C.-H.; Lee T.-A.; WAN-WAN LIN |
| 國立臺灣大學 |
2015 |
EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway
|
Tsai, Meng-Feng; Chang, Tzu-Hua; Wu, Shang-Gin; Yang, Hsiao-Yin; Hsu, Yi-Chiung; Yang, Pan-Chyr; Shih, Jin-Yuan; 楊泮池; 吳尚俊; 施金元 |
| 臺大學術典藏 |
2018-09-10T15:17:53Z |
EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway
|
Tsai, Meng-Feng; Chang, Tzu-Hua; Wu, Shang-Gin; Yang, Hsiao-Yin; Hsu, Yi-Chiung; Yang, Pan-Chyr; Shih, Jin-Yuan; 楊泮池; JIN-YUAN SHIH; Yang, Pan-Chyr |
| 臺大學術典藏 |
2020-08-12T08:25:23Z |
EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway
|
Shih J.-Y.; Tsai M.-F.; Chang T.-H.; SHANG-GIN WU; Yang H.-Y.; Hsu Y.-C.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:41Z |
EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway
|
Yang P.-C.; Hsu Y.-C.; Tsai M.-F.; Chang T.-H.; Wu S.-G.; Yang H.-Y.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-12-02T02:33:29Z |
EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway
|
Tsai M.-F.; Chang T.-H.; Wu S.-G.; Yang H.-Y.; Hsu Y.-C.; Pan-Chyr Yang; Shih J.-Y.; Tsai M.-F.; Chang T.-H.; Wu S.-G.; Yang H.-Y.; Hsu Y.-C.; PAN-CHYR YANG; Shih J.-Y. |
| 大葉大學 |
2015-09 |
EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway.
|
Tsai, Meng-Feng;TH, Chang;SG, Wu;HY, Yang;YC, Hsu;PC, Yang;JY, Shih |
| 臺大學術典藏 |
2019-11-08T03:21:46Z |
EGFR-Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic Drugs
|
Chang, Chia-Ching; CHONG-JEN YU; PAN-CHYR YANG; CHAO-CHI HO; CHAO-CHI HO;PAN-CHYR YANG;CHONG-JEN YU;Chang, Chia-Ching;Lin, Shr-Uen;HUEI-WEN CHEN;Chen, Hsuan-Yu;SUNG-LIANG YU;Lin, Chih-An; Lin, Chih-An; SUNG-LIANG YU; Chen, Hsuan-Yu; HUEI-WEN CHEN; Lin, Shr-Uen |
| 臺大學術典藏 |
2020-06-17T03:01:28Z |
EGFR-Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic Drugs
|
Lin C.-A.;Sung-Liang Yu;Chen H.-Y.;Chen H.-W.;Lin S.-U.;Chang C.-C.;Yu C.-J.;Yang P.-C.;Ho C.-C.; Lin C.-A.; SUNG-LIANG YU; Chen H.-Y.; Chen H.-W.; Lin S.-U.; Chang C.-C.; Yu C.-J.; Yang P.-C.; Ho C.-C. |
| 臺大學術典藏 |
2020-07-21T06:46:17Z |
EGFR-Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic Drugs
|
Lin C.-A.; Yu S.-L.; Chen H.-Y.; Chen H.-W.; Lin S.-U.; Chang C.-C.; Yu C.-J.; Yang P.-C.; CHAO-CHI HO |
| 臺大學術典藏 |
2020-08-12T02:50:37Z |
EGFR-Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic Drugs
|
Yu S.-L.; Lin C.-A.; Lin C.-A.;Yu S.-L.;Chen H.-Y.;Chen H.-W.;Lin S.-U.;Chang C.-C.;Yu C.-J.;Yang P.-C.;Chao-Chi Ho; Chen H.-Y.; Chen H.-W.; Lin S.-U.; Chang C.-C.; Yu C.-J.; Yang P.-C.; CHAO-CHI HO |
| 臺大學術典藏 |
2020-08-12T06:34:20Z |
EGFR-Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic Drugs
|
Ho C.-C.; Yang P.-C.; CHONG-JEN YU; Chang C.-C.; Lin S.-U.; Chen H.-W.; Chen H.-Y.; Yu S.-L.; Lin C.-A.; Lin C.-A.;Yu S.-L.;Chen H.-Y.;Chen H.-W.;Lin S.-U.;Chang C.-C.;Chong-Jen Yu;Yang P.-C.;Ho C.-C. |
| 臺大學術典藏 |
2022-03-09T03:12:20Z |
EGFR-Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic Drugs
|
Lin C.-A.; Yu S.-L.; Chen H.-Y.; HUEI-WEN CHEN; Lin S.-U.; Chang C.-C.; Yu C.-J.; Yang P.-C.; Ho C.-C. |
| 臺大學術典藏 |
2020-12-02T02:33:09Z |
EGFR-Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic Drugs
|
Lin C.-A.;Yu S.-L.;Chen H.-Y.;Chen H.-W.;Lin S.-U.;Chang C.-C.;Yu C.-J.;Pan-Chyr Yang;Ho C.-C.; Lin C.-A.; Yu S.-L.; Chen H.-Y.; Chen H.-W.; Lin S.-U.; Chang C.-C.; Yu C.-J.; PAN-CHYR YANG; Ho C.-C. |
| 臺大學術典藏 |
2022-06-27T06:59:54Z |
EGFR-Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic Drugs
|
Lin C.-A.; Yu S.-L.; Chen H.-Y.; Chen H.-W.; Lin S.-U.; Chang C.-C.; CHONG-JEN YU; Yang P.-C.; Ho C.-C. |
| 臺大學術典藏 |
2020-02-27T06:39:23Z |
EGFR-targeted micelles containing near-infrared dye for enhanced photothermal therapy in colorectal cancer
|
Shih Y.-H.;Luo T.-Y.;Chiang P.-F.;Yao C.-J.;Lin W.-J.;Peng C.-L.;Ming-Jium Shieh; Shih Y.-H.; Luo T.-Y.; Chiang P.-F.; Yao C.-J.; Lin W.-J.; Peng C.-L.; MING-JIUM SHIEH |
| 國立臺灣海洋大學 |
2018-02 |
EGFR-Targeted Photodynamic Therapy by Curcumin-Encapsulated Chitosan/TPP Nanoparticles
|
Wen-Hsuan Tsai; Kun-Hua Yu; Yi-Cheng Huang; Cheng-I Lee |
| 國立臺灣海洋大學 |
2017-12 |
EGFR-Targeted Photodynamic Therapy by Curcumin-Encapsulated Chitosan/TPP Nanoparticles.
|
Yi-Cheng Huang; Cheng-I Lee; Kun-Hua Yu; Wen-Hsuan Tsai |
| 臺大學術典藏 |
2020-02-27T06:39:28Z |
EGFR-targeting peptide conjugated ph-sensitive micelles as a potential drug carrier for photodynamic detection and therapy of cancer
|
Peng C.-L.;Chen Y.-I.;Shih Y.-H.;Luo T.-Y.;Ming-Jium Shieh; Peng C.-L.; Chen Y.-I.; Shih Y.-H.; Luo T.-Y.; MING-JIUM SHIEH |
| 國立成功大學 |
2021-09 |
EGFR-TKI plus bevacizumab versus EGFR-TKI monotherapy for patients with EGFR mutation-positive advanced non-small cell lung cancer-A propensity score matching analysis
|
Tsai;Jeng-Shiuan;Su;Po-Lan;Yang;Szu-Chun;Chang;Chao-Chun;Lin;Chia-Ying;Yen;Yi-Ting;Tseng;Yau-Lin;Lai;Wu-Wei;Lin;Chien-Chung;Su;Wu-Chou |
| 國立交通大學 |
2018-01-24T07:39:25Z |
EGFR-TKI小分子標靶藥物治療非小細胞肺癌之細胞反應與藥物交互作用
|
王祥宇; 曾慶平; 徐祖安; Wang, Hsian-Yu; Tseng, Ching-Ping; Hsu, John T. -A. |
| 中國醫藥大學 |
2008-06-30 |
EGFR/JNK訊息路徑當作前列腺癌骨骼轉移治療標的研究
|
魏宗德(Tzong-Der Way) |
| 中國醫藥大學 |
2013-09 |
EGFR/SGLT1Interaction Does Not Respond to EGFR Modulators, But Inhibition of SGLT1 Sensitizes Prostate Cancer Cells to EGFR Tyrosine Kinase Inhibitors
|
(Jiangong Ren);(Lakshmi R. Bollu);(Fei Su);(Guang Gao);(Lei Xu);黃偉謙(Wei-Chien Huang);洪明奇(Mien-Chie Hung);(Zhang Weihua) |
